INVESTMENTS IN CONSOLIDATED AND UNCONSOLIDATED ENTITIES - Summarized Statements of Operations of Unconsolidated Entities Accounted by Equity Method (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Schedule of Equity Method Investments [Line Items]
Costs and expenses	$ (1,453,543)	$ (1,390,577)	$ (2,763,539)	$ (2,533,948)
Net income	293,154	124,755	471,615	227,198
Equity Method Investments | Equity Method Investment, Nonconsolidated Investee or Group of Investees
Schedule of Equity Method Investments [Line Items]
Revenues	94,166	29,745	124,567	79,626
Costs and expenses	(94,086)	(22,901)	(119,016)	(57,059)
Net income	80	6,844	5,551	22,567
TMHC’s share in (loss)/income of unconsolidated entities	(3,637)	2,126	(1,806)	7,788
Distributions to TMHC from unconsolidated entities	$ 88,770	$ 9,729	$ 90,828	$ 20,342